We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Half of Older US Adults Now Take Aspirin

By HospiMedica International staff writers
Posted on 27 Apr 2015
A new study claims that 52% of older adults in the United States take a daily dose of aspirin, even though it is not recommended for those who have not yet had a heart attack or stroke.

Researchers at Oregon State University (OSU; Corvallis, USA), Oregon Health & Science University (Portland, USA), and other institutions conducted a survey of US adults aged 45–75 years (mean age 60) to ascertain aspirin use and factors associated with that use. More...
The results showed that among the 2,509 respondents, 52% reported current aspirin use, and another 21% had used it at some point in the past. Among the 2,039 respondents without a history of cardiovascular disease (CVD), current use of aspirin was 47%.

Out of the older adults who are now using aspirin, 81% have not had a heart attack or stroke, and are taking it for primary prevention, associated with the presence of major CVD risk factors, including heart attack prevention (84%); stroke prevention (66%); cancer prevention (18%); and prevention of Alzheimer's disease (11%). Other reasons cited include high self-assessed knowledge of aspirin and having discussed aspirin therapy with a health provider.

Several markers of healthy lifestyle choices were also associated with regular use, with significant predictors including people who were physically active, ate healthy foods, had achieved a healthy weight, managed their stress, tried to quit smoking, and/or had undergone health screenings. The study was published in the May 2015 issue of the American Journal of Preventive Medicine.

“There's no doubt that aspirin use can have value for people who have experienced a first heart attack, stroke or angina; the data to support that is very strong. The support of its use in primary prevention is more of a mixed bag,” said lead author Prof. Craig Williams, PharmaD, of OSU and OHSU. “But this survey clearly shows that more and more people who have not experienced those events and are not technically considered at high risk by the FDA are also deciding to use aspirin, usually in consultation with their doctors.”

“Surveys such as this are needed to help determine how people are managing their own health, since aspirin is an over-the-counter medication and its use cannot be determined solely by medical records,” added professor Williams. “The findings suggest that tens of millions of Americans have reviewed the issues involved, often discussed it with their doctors, say they know what they are doing—and decided to use aspirin.”

Related Links:

Oregon State University
Oregon Health & Science University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.